BioCryst ends internal discovery programs, will close Alabama research facility

June 29, 2026 11:23 AM EDTUpdated 11:38 AM R&D BioCryst ends in­ter­nal dis­cov­ery pro­grams, will close Al­aba­ma re­search fa­cil­i­ty Lei Lei Wu News Reporter BioCryst Phar­ma­ceu­ti­cals is wind­ing down its own drug dis­cov­ery work, say­ing that it plans to look for fu­ture drug pro­grams ex­ter­nal­ly. The com­pa­ny Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER